LICENSE AGREEMENTLicense Agreement • October 19th, 2020 • Tottenham Acquisition I LTD • Blank checks • Delaware
THIS LICENSE AGREEMENT (“Agreement”) and the Supply Agreement are being entered between CLENE NANOMEDICINE, INC., a Delaware corporation (“Clene”) and 4LIFE RESEARCH, LLC, a Utah limited liability company (“4Life”) effective as of August 31, 2018 (the “Effective Date”). Clene and 4Life are sometimes collectively referred to herein collectively as the “Parties” or individually as a “Party.”
HEALEY ALS PLATFORM TRIAL CLINICAL RESEARCH SUPPORT AGREEMENTClinical Research Support Agreement • October 19th, 2020 • Tottenham Acquisition I LTD • Blank checks • Massachusetts
THIS CLINICAL RESEARCH SUPPORT AGREEMENT (“Agreement”) is made and entered into as of September 27, 2019 (“Effective Date”) by and between Clene Nanomedicine, Inc. (“Company”) a Delaware corporation, duly organized under law, and having an address at 3165 E. Millrock Drive, Suite 325, Salt Lake City, UT 84121 and The General Hospital Corporation d/b/a Massachusetts General Hospital (“MGH”), a not-for-profit corporation organized under the laws of Massachusetts with its principal place of business at 55 Fruit Street, Boston, MA 02114. MGH and Company are each a (“Party”) to the Agreement and are collectively, the (“Parties”).
